Health Care·Health Care Equipment·$12.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.01 | N/A | -115.87% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.01 | N/A | -115.87% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Overall, management expressed concerns about current market conditions. They did not provide specific guidance for the upcoming quarters.
Management did not provide specific revenue figures for the quarter.
The company acknowledged challenges in meeting expectations.
Penumbra Inc's earnings report shows a significant miss on EPS, which likely contributed to the stock's decline of 1.72% following the announcement. The lack of revenue figures and guidance may raise concerns among investors about the company's performance and outlook. Overall, the results indicate challenges that could impact future growth.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ENTERPRISE PRODS PAR
May 2, 2022